Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief Operating Officer sold 1,244 shares at $12.01 ($14,940)
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations · Executive or director change
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Grant or award Director acquired 6,689 shares (grant or award)
  10. 4 Grant or award Director acquired 6,689 shares (grant or award)
  11. 4 Grant or award Director acquired 6,689 shares (grant or award)
  12. 4 Grant or award Director acquired 6,689 shares (grant or award)
  13. 4 Grant or award Director acquired 6,689 shares (grant or award)
  14. 4 Grant or award Director acquired 6,689 shares (grant or award)
  15. 4 Grant or award Director acquired 6,689 shares (grant or award)
  16. 4 Open-market sale Chief Operating Officer sold 1,021 shares at $23.32 ($23,810)
  17. 8-K Event Results of operations · Executive or director change
  18. 4 Open-market sale SVP and General Counsel sold 15,338 shares at $30.00 ($460,140)
  19. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
  20. 4 Open-market sale Chief Scientific Officer sold 4,000 shares at an average $32.00 ($127,993)

Page 20 of 42 · 837 filings